360 related articles for article (PubMed ID: 22801493)
1. TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis.
Gregory AP; Dendrou CA; Attfield KE; Haghikia A; Xifara DK; Butter F; Poschmann G; Kaur G; Lambert L; Leach OA; Prömel S; Punwani D; Felce JH; Davis SJ; Gold R; Nielsen FC; Siegel RM; Mann M; Bell JI; McVean G; Fugger L
Nature; 2012 Aug; 488(7412):508-511. PubMed ID: 22801493
[TBL] [Abstract][Full Text] [Related]
2. Clinical relevance and functional consequences of the TNFRSF1A multiple sclerosis locus.
Ottoboni L; Frohlich IY; Lee M; Healy BC; Keenan BT; Xia Z; Chitnis T; Guttmann CR; Khoury SJ; Weiner HL; Hafler DA; De Jager PL
Neurology; 2013 Nov; 81(22):1891-9. PubMed ID: 24174586
[TBL] [Abstract][Full Text] [Related]
3. TNFRSF1A polymorphisms rs1800693 and rs4149584 in patients with multiple sclerosis.
Comabella M; Caminero AB; Malhotra S; Agulló L; Fernández O; Reverter F; Vandenbroeck K; Rodríguez-Antigüedad A; Matesanz F; Izquierdo G; Urcelay E; López-Larios A; Sánchez A; Otero S; Tintoré M; Montalban X
Neurology; 2013 May; 80(22):2010-6. PubMed ID: 23624563
[TBL] [Abstract][Full Text] [Related]
4. Association of TNFAIP3 and TNFRSF1A variation with multiple sclerosis in a German case-control cohort.
Hoffjan S; Okur A; Epplen JT; Wieczorek S; Chan A; Akkad DA
Int J Immunogenet; 2015 Apr; 42(2):106-10. PubMed ID: 25684197
[TBL] [Abstract][Full Text] [Related]
5. A clinical conundrum: the detrimental effect of TNF antagonists in multiple sclerosis.
Dendrou CA; Bell JI; Fugger L
Pharmacogenomics; 2013 Sep; 14(12):1397-404. PubMed ID: 24024893
[TBL] [Abstract][Full Text] [Related]
6. Tumor Necrosis Factor Inhibition and Parkinson Disease: A Mendelian Randomization Study.
Kang X; Ploner A; Pedersen NL; Bandres-Ciga S; Noyce AJ; Wirdefeldt K; Williams DM
Neurology; 2021 Mar; 96(12):e1672-e1679. PubMed ID: 33608417
[TBL] [Abstract][Full Text] [Related]
7. Role of tumour necrosis factor (TNF)-α and TNFRSF1A R92Q mutation in the pathogenesis of TNF receptor-associated periodic syndrome and multiple sclerosis.
Caminero A; Comabella M; Montalban X
Clin Exp Immunol; 2011 Dec; 166(3):338-45. PubMed ID: 22059991
[TBL] [Abstract][Full Text] [Related]
8. [Association analysis of cytokine receptors' genes polymorphisms with clinical features of multiple sclerosis].
Kulakova OG; Bashinskaya VV; Tsareva EY; Boyko AN; Favorova OO; Gusev EI
Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(10. Vyp. 2):10-15. PubMed ID: 28139605
[TBL] [Abstract][Full Text] [Related]
9. Frequency of tumour necrosis factor alpha receptor superfamily 1A multiple sclerosis-associated variants in patients with rheumatoid arthritis with anti-tumour necrosis factor therapy-related demyelinating complications.
Bitoun S; Miceli-Richard C; Verstuyft C; Juge PA; Dieudé P; Berthelot JM; Richez C; Cauquil C; Sordet C; Melac-Ducamp S; Gossec L; Bouvard B; Dernis E; Houvenagel E; Boutry-Bacle MA; Mariette X; Seror R
Ann Rheum Dis; 2018 Dec; 77(12):1835-1836. PubMed ID: 30030263
[No Abstract] [Full Text] [Related]
10. Genetic variants associated with autoimmunity drive NFκB signaling and responses to inflammatory stimuli.
Housley WJ; Fernandez SD; Vera K; Murikinati SR; Grutzendler J; Cuerdon N; Glick L; De Jager PL; Mitrovic M; Cotsapas C; Hafler DA
Sci Transl Med; 2015 Jun; 7(291):291ra93. PubMed ID: 26062845
[TBL] [Abstract][Full Text] [Related]
11. Associations of CD6, TNFRSF1A and IRF8 polymorphisms with risk of inflammatory demyelinating diseases.
Park TJ; Kim HJ; Kim JH; Bae JS; Cheong HS; Park BL; Shin HD
Neuropathol Appl Neurobiol; 2013 Aug; 39(5):519-30. PubMed ID: 22994200
[TBL] [Abstract][Full Text] [Related]
12. Replication analysis of variants associated with multiple sclerosis risk.
Dashti M; Ateyah K; Alroughani R; Al-Temaimi R
Sci Rep; 2020 Apr; 10(1):7327. PubMed ID: 32355262
[TBL] [Abstract][Full Text] [Related]
13. Tumor necrosis factor (TNF) and TNFR1 polymorphisms are not risk factors for rheumatoid arthritis in a Mexican population.
Cadena-Sandoval D; Alemán-Ávila I; Barbosa-Cobos RE; Becerril-Mendoza LT; Fragoso JM; Ramírez-Bello J
Mol Biol Rep; 2018 Jun; 45(3):227-232. PubMed ID: 29404828
[TBL] [Abstract][Full Text] [Related]
14. GWAS-identified multiple sclerosis risk loci involved in immune response: validation in Russians.
Bashinskaya VV; Kulakova OG; Kiselev IS; Baulina NM; Favorov AV; Boyko AN; Tsareva EY; Favorova OO
J Neuroimmunol; 2015 May; 282():85-91. PubMed ID: 25903733
[TBL] [Abstract][Full Text] [Related]
15. Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci.
De Jager PL; Jia X; Wang J; de Bakker PI; Ottoboni L; Aggarwal NT; Piccio L; Raychaudhuri S; Tran D; Aubin C; Briskin R; Romano S; ; Baranzini SE; McCauley JL; Pericak-Vance MA; Haines JL; Gibson RA; Naeglin Y; Uitdehaag B; Matthews PM; Kappos L; Polman C; McArdle WL; Strachan DP; Evans D; Cross AH; Daly MJ; Compston A; Sawcer SJ; Weiner HL; Hauser SL; Hafler DA; Oksenberg JR
Nat Genet; 2009 Jul; 41(7):776-82. PubMed ID: 19525953
[TBL] [Abstract][Full Text] [Related]
16. Association of TNF-α, TNFRSF1A and TNFRSF1B gene polymorphisms with the risk of sporadic breast cancer in northeast Chinese Han women.
Xu F; Zhou G; Han S; Yuan W; Chen S; Fu Z; Li D; Zhang H; Li D; Pang D
PLoS One; 2014; 9(7):e101138. PubMed ID: 25010932
[TBL] [Abstract][Full Text] [Related]
17. The genetic association of variants in CD6, TNFRSF1A and IRF8 to multiple sclerosis: a multicenter case-control study.
International Multiple Sclerosis Genetics Consortium
PLoS One; 2011 Apr; 6(4):e18813. PubMed ID: 21552549
[TBL] [Abstract][Full Text] [Related]
18. The severity of ankylosing spondylitis and responses to anti-tumour necrosis factor biologics are not influenced by the tumour necrosis factor receptor polymorphism incriminated in multiple sclerosis.
Watts L; Karaderi T; Roberts A; Appleton L; Wordsworth T; Cohen C; Wordsworth P; Vecellio M
Genes Immun; 2019 Feb; 20(2):167-171. PubMed ID: 29535371
[TBL] [Abstract][Full Text] [Related]
19. The tumor necrosis factor receptor superfamily member 1B polymorphisms predict response to anti-TNF therapy in patients with autoimmune disease: A meta-analysis.
Chen W; Xu H; Wang X; Gu J; Xiong H; Shi Y
Int Immunopharmacol; 2015 Sep; 28(1):146-53. PubMed ID: 26071216
[TBL] [Abstract][Full Text] [Related]
20. Multiple sclerosis. TNFRSF1A, TRAPS and multiple sclerosis.
Kümpfel T; Hohlfeld R
Nat Rev Neurol; 2009 Oct; 5(10):528-9. PubMed ID: 19794511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
